Publicaciones en colaboración con investigadores/as de Necker-Enfants Malades Hospital (16)

2023

  1. Treatment and long-term outcome in primary nephrogenic diabetes insipidus

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 10, pp. 2120-2130

2022

  1. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents

    Pediatric Diabetes

2018

  1. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents

    Pediatric Diabetes, Vol. 19, pp. 47-63

  2. Symptomatic management of febrile illnesses in children: A systematic review and meta-analysis of parents' knowledge and behaviors and their evolution over time

    Frontiers in Pediatrics, Vol. 6

  3. Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes

    Pediatric Diabetes, Vol. 19, Núm. 3, pp. 559-565

2017

  1. International variability in gastrointestinal decontamination with acute poisonings

    Pediatrics, Vol. 140, Núm. 2

2016

  1. The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus

    Molecular and Cellular Endocrinology, Vol. 419, pp. 83-91

2015

  1. Classifying insulin regimens - difficulties and proposal for comprehensive new definitions

    Pediatric Diabetes, Vol. 16, Núm. 6, pp. 402-406

2014

  1. Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step pcrbased enrichment in combination with next-generation sequencing

    Diabetes Care, Vol. 37, Núm. 2, pp. 460-467

2013

  1. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus

    Diabetes Technology and Therapeutics

  2. Lessons from the Hvidoere International Study Group on childhood diabetes: Be dogmatic about outcome and flexible in approach

    Pediatric Diabetes, Vol. 14, Núm. 7, pp. 473-480

  3. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: The Hvidoere study in young children 2009

    Pediatric Diabetes, Vol. 14, Núm. 6, pp. 422-428

2012

  1. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus

    New England Journal of Medicine, Vol. 366, Núm. 5, pp. 433-442

  2. PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 12

2007

  1. New ABCC8 mutations in relapsing neonatal diabetes and clinical features

    Diabetes, Vol. 56, Núm. 6, pp. 1737-1741

1987

  1. Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients

    Journal of Clinical Investigation, Vol. 80, Núm. 6, pp. 1607-1612